PT - JOURNAL ARTICLE AU - Deng, Jingyu AU - Liang, Han TI - D2 Lymphadenectomy in Gastric Cancer Surgery AID - 10.1007/s11805-009-0162-3 DP - 2009 Jun 01 TA - Clinical Oncology and Cancer Research PG - 162--168 VI - 6 IP - 3 4099 - http://www.cancerbiomed.org/content/6/3/162.short 4100 - http://www.cancerbiomed.org/content/6/3/162.full SO - Cancer Biol Med2009 Jun 01; 6 AB - Gastric cancer is one of the most common causes of cancer death worldwide. Surgery is the most widely utilized treatment for resectable gastric cancer. Evidence indicates that lymph node involvement and depth of invasion of the primary tumor are the most important prognostic factors for gastric cancer patients. Therefore, lymph node clearance is deemed a key procedure in gastric cancer surgery for the prognostic value to patients. Although the appropriate lymphadenectomy during gastrectomy for cancer still remains controversial, extended lymph node dissection (D2 lymphadenectomy) should be recommended in high volume hospitals.